About AbTis
AbTis is a company based in Suwon (South Korea) founded in 2016 by Sang Jeon Chung.. AbTis has raised $4.5 million across 1 funding round from investors including JX Partners, Stonebridge Capital and K2 Investment Partners. AbTis operates in a competitive market with competitors including Sino Biological, GenScript, Mabtech, Y-Biologics and Epitomics, among others.
- Headquarter Suwon, South Korea
- Founders Sang Jeon Chung
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.5 M (USD)
in 1 rounds
-
Latest Funding Round
$4.5 M (USD), Seed
Jun 01, 2018
-
Investors
JX Partners
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of AbTis
AbTis has successfully raised a total of $4.5M through 1 strategic funding round. The most recent funding activity was a Seed round of $4.5 million completed in June 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $4.5M
-
First Round
First Round
(01 Jun 2018)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2018 | Amount | Seed - AbTis | Valuation | JX Partners , Stonebridge Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in AbTis
AbTis has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include JX Partners, Stonebridge Capital and K2 Investment Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Early-stage tech and life sciences focused VC & PE firm
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by AbTis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AbTis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Abtis Comparisons
Competitors of AbTis
AbTis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sino Biological, GenScript, Mabtech, Y-Biologics and Epitomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Reagents and kits are provided for clinical research applications.
|
|
| domain | founded_year | HQ Location |
Reagents and instruments are provided for life sciences research.
|
|
| domain | founded_year | HQ Location |
Antibodies and immunoassay kits are developed for research applications.
|
|
| domain | founded_year | HQ Location |
Developer of antibodies for the treatment of multiple diseases
|
|
| domain | founded_year | HQ Location |
Monoclonal antibody technology and products are developed by Epitomics.
|
|
| domain | founded_year | HQ Location |
Antibody and vaccine culture media products are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Abtis
Frequently Asked Questions about AbTis
When was AbTis founded?
AbTis was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Where is AbTis located?
AbTis is headquartered in Suwon, South Korea. It is registered at Suwon, Gyeonggi, South Korea.
Who is the current CEO of AbTis?
Sang Jeon Chung is the current CEO of AbTis. They have also founded this company.
Is AbTis a funded company?
AbTis is a funded company, having raised a total of $4.5M across 1 funding round to date. The company's 1st funding round was a Seed of $4.5M, raised on Jun 01, 2018.
What does AbTis do?
AbTis was founded in 2016 in Suwon-si, South Korea, where operations focus on biotechnology for antibody-drug conjugates. Proprietary technologies, including the AbTis linker for site-specific binding and AbTis Michelle for drug solubility, are offered. The pipeline also encompasses monoclonal antibody drug conjugates. Leadership is provided by founder and CEO Sang Jeon Chung.
Who are the top competitors of AbTis?
AbTis's top competitors include Sino Biological, GenScript and Y-Biologics.
Who are AbTis's investors?
AbTis has 3 investors. Key investors include JX Partners, Stonebridge Capital, and K2 Investment Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.